Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q3 2021 Results – Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET
Company Participants
Joseph Kim – President and CEO
Ben Matone – Senior Director of Investor Relations
Peter Kies – Chief Financial Officer
Jackie Shea…

Click here to view the original article.